Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
2009

Effects of Cerebrolysin on Neurorehabilitation

Sample size: 139 publication Evidence: moderate

Author Information

Author(s): Onose G, Mureşanu DF, Ciurea AV, Chendreanu CD, Mihaescu AS, Mardare DC, Andone I, SpȦnu A, Popescu C, Dumitrescu A, Popescu M, Grigorean V, Ungur B, Marinescu F, Colibaşeanu I, Onose L, Haras M, Sandu A, Spircu T

Primary Institution: ‘Bagdasar–Arseni’ Teaching Emergency Hospital, Bucharest, Romania

Hypothesis

Does Cerebrolysin improve neurorehabilitative outcomes in patients compared to those who do not receive it?

Conclusion

Cerebrolysin administration significantly hastens the recovery of critical parameters for standing and walking.

Supporting Evidence

  • Cerebrolysin significantly improved the speed of achieving functional recovery.
  • Patients treated with Cerebrolysin showed better outcomes in knee functional extension.
  • The study included a comparative analysis of 139 patients.

Takeaway

Cerebrolysin helps people recover faster after brain injuries, especially in walking and standing.

Methodology

Comparative analysis of patients treated with Cerebrolysin versus non-treated controls over a period of three weeks.

Potential Biases

Potential selection bias due to the random allocation of patients based on pharmacy availability.

Limitations

The study had a relatively small sample size and was limited to specific patient demographics.

Participant Demographics

69 treated patients (22 females, 47 males; average age 61) and 70 controls (41 females, 29 males; average age 70.5).

Statistical Information

P-Value

p=0.0007 for KE; p=0.0000 for WPB

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication